Armistice Capital’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
Armistice Capital's BNTX Position: Q3 2026 in Review
Armistice Capital opened a new position in BioNTech (BNTX) in Q3 2026: 164,000 shares worth $16.1M. The stake represents 0.2% of the portfolio and ranks #74 among its holdings. This is a return to the name: Armistice Capital previously reported a position in BNTX as recently as Q1 2023.
Armistice Capital first reported a position in BNTX in Q3 2020 and has held it in 12 quarters since. The position peaked at $30.1M in Q1 2021. 302 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.
- Armistice Capital held 164,000 shares of BioNTech worth $16.1M as of Q3 2026.
- BioNTech was a new Armistice Capital position in Q3 2026.
- BioNTech made up 0.2% of Armistice Capital's portfolio in Q3 2026, its #74 holding.
- Armistice Capital first reported a position in BioNTech in Q3 2020 and has held it in 12 quarters since.
- Armistice Capital's BioNTech position peaked at $30.1M in Q1 2021.
- 302 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.
Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.